Table 3.

Summary of recommendations for newly diagnosed NLPHL

Stage	Treatment
Stage IA	30-Gy IS-RT alone
Early stages except for stage IA	2 × (R-)ABVD + 20-Gy IS-RT
Intermediate stages	4 × (R-)ABVD + 30-Gy IF-RT
Advanced stages	6 × R-CHOP ± localized RT at 30 Gy

ABVD, doxorubicin, bleomycin, vinblastine, dacarbazine; IF-RT, involved-field radiotherapy; IS-RT, involved-site radiotherapy; NLPHL, nodular lymphocyte-predominant Hodgkin lymphoma; R, rituximab; R-CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone; RT, radiotherapy.